Edwards Lifesciences Corp — Director's Dealing 2016

Jul 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2016-07-14

Reporting Person: STONE HEISZ LESLIE (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-14	Director Stock Option (Right to Acquire)	$107.0300	A	6557.0000	Acquired	2023-07-13	Common Stock (6557.0000)	Direct

Footnotes

F1: This option was granted on July 14, 2016 under the Edwards Lifesciences Nonemployee Directors Stock Incentive Program and becomes exercisable 33% per year for three years commencing on the first anniversary of the grant date until fully vested.

F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.